Therefore, given the important role of ABPs in cellular motility and the lack of data regarding the CTC architecture cytoskeleton, it is important to study the levels of CFL1, PFN1, and CAP1 in CTCs and systemic leukocytes in cancer patients. This evidence concerns the gene CAP1 and cancer.